Table 1.
Summary table detailing existing case reports and case series on esophagitis dissecans superficialis, highlighting the suspected etiological factors and clinical management.
Endoscopic Follow-Up | Treatment | Biopsy | Etiology | Patient | Author, Year, [Ref.] |
---|---|---|---|---|---|
Follow-up endoscopy at 1 week (healed) | Liquid diet, iron supplementation was withheld |
Yes | Medication-induced esophagitis (oral iron supplementation) | 94-year-old male | Nasir UM et al., 2020 [31] |
Follow-up endoscopy at 1 year (healed) | High-dose proton pump inhibitor | Yes | COVID-19 infection | 68-year-old female | Salehi AM et al., 2022 [32] |
None | Oral diclofenac was discontinued, treated with oral sucralfate and high-dose proton pump inhibitor | Yes | Medication-induced esophagitis (oral diclofenac) | 54-year-old male | Senyondo G et al., 2022 [33] |
None | Oral prednisone | Yes | Autoimmune disease (bullous pemphigoid) | 67-year-old male | Morel-Cerda EC et al., 2020 [34] |
None | Double-dose proton pump inhibitor and sucralfate | Yes | Treatment with tyrosine kinase inhibitor | 70-year-old male | Kanagalingam G et al., 2021 [22] |
None | Oral proton pump inhibitor and sucralfate | No | Treatment with metotrexate | 57-year-old male | Venkata R et al., 2020 [23] |
Follow-up endoscopy at 1 week (healed) | Intravenous proton pump inhibitor | No | Following hematopoietic stem cell transplantation | 18-year-old female, 29-year-old male, 21-year-old male, 16-year-old male | Iwamuro M et al., 2020 [24] |
None | Proton pump inhibitor treatment | Yes | Treatment with dabigatran | 77-year-old women | Zhou Y et al., 2020 [25] |
Follow-up endoscopy at 1 week (healed) | Double-dose proton pump inhibitor | Yes | Treatment with sunitinib | 66-year-old male | Gayam S et al., 2016 [20] |
Yes (healed) | Steroid treatment | Yes | Dermatomyositis | 36-year-old male | Zheng W et al., 2021 [26] |